0001171843-23-001737.txt : 20230316 0001171843-23-001737.hdr.sgml : 20230316 20230316171516 ACCESSION NUMBER: 0001171843-23-001737 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230316 ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Oncology Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36790 FILM NUMBER: 23739780 BUSINESS ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 BUSINESS PHONE: 651-389-4800 MAIL ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutics Inc. DATE OF NAME CHANGE: 20180314 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutic Inc. DATE OF NAME CHANGE: 20180208 FORMER COMPANY: FORMER CONFORMED NAME: Skyline Medical Inc. DATE OF NAME CHANGE: 20130807 8-K 1 f8k_031623.htm FORM 8-K Form 8-K
0001446159 False 12/31 0001446159 2023-03-16 2023-03-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  March 16, 2023

_______________________________

Predictive Oncology Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware 001-36790 33-1007393
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

2915 Commers Drive, Suite 900

Eagan, Minnesota 55121

(Address of Principal Executive Offices) (Zip Code)

(651) 389-4800

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, $0.01 par value POAI Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 3.03. Material Modification to Rights of Security Holders.

The disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Series F Preferred Stock

On March 16, 2023, the board of directors (the “Board”) of Predictive Oncology Inc. (the “Company”) declared a dividend of one one-thousandth of a share of Series F Preferred Stock, par value $0.01 per share (“Series F Preferred Stock”), for each outstanding share of the Company’s common stock, par value $0.01 per share (“Common Stock”) to stockholders of record at 5:00 p.m. Eastern Time on March 27, 2023 (the “Record Date”).

General; Transferability. Shares of Series F Preferred Stock will be uncertificated and represented in book-entry form. No shares of Series F Preferred Stock may be transferred by the holder thereof except in connection with a transfer by such holder of any shares of Common Stock held by such holder, in which case a number of one one-thousandths (1/1,000ths) of a share of Series F Preferred Stock equal to the number of shares of Common Stock to be transferred by such holder will be automatically transferred to the transferee of such shares of Common Stock.

Voting Rights. Each share of Series F Preferred Stock will entitle the holder thereof to 1,000,000 votes per share (and, for the avoidance of doubt, each fraction of a share of Series F Preferred Stock will have a ratable number of votes). Thus, each one-thousandth of a share of Series F Preferred Stock would entitle the holder thereof to 1,000 votes. The outstanding shares of Series F Preferred Stock will vote together with the outstanding shares of Common Stock of the Company as a single class exclusively with respect to (1) any proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to reclassify the outstanding shares of Common Stock into a smaller number of shares of Common Stock at a ratio specified in or determined in accordance with the terms of such amendment (the “Reverse Stock Split”) and (2) any proposal to adjourn any meeting of stockholders called for the purpose of voting on Reverse Stock Split (the “Adjournment Proposal”). The Series F Preferred Stock will not be entitled to vote on any other matter, except to the extent required under the Delaware General Corporation Law.

Unless otherwise provided on any applicable proxy or ballot with respect to the voting on the Reverse Stock Split or the Adjournment Proposal, the vote of each share of Series F Preferred Stock (or fraction thereof) entitled to vote on the Reverse Stock Split, the Adjournment Proposal or any other matter brought before any meeting of stockholders held to vote on the Reverse Stock Split and the Adjournment Proposal will be cast in the same manner as the vote, if any, of the share of Common Stock (or fraction thereof) in respect of which such share of Series F Preferred Stock (or fraction thereof) was issued as a dividend is cast on the Reverse Stock Split, the Adjournment Proposal or such other matter, as applicable, and the proxy or ballot with respect to shares of Common Stock held by any holder on whose behalf such proxy or ballot is submitted will be deemed to include all shares of Series F Preferred Stock (or fraction thereof) held by such holder. Holders of Series F Preferred Stock will not receive a separate ballot or proxy to cast votes with respect to the Series F Preferred Stock on the Reverse Stock Split, the Adjournment Proposal or any other matter brought before any meeting of stockholders held to vote on the Reverse Stock Split.

Dividend Rights. The holders of Series F Preferred Stock, as such, will not be entitled to receive dividends of any kind.

Liquidation Preference. The Series F Preferred Stock will rank senior to the Common Stock as to any distribution of assets upon a liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily (a “Dissolution”). Upon any Dissolution, each holder of outstanding shares of Series F Preferred Stock will be entitled to be paid out of the assets of the Company available for distribution to stockholders, prior and in preference to any distribution to the holders of Common Stock, an amount in cash equal to $0.01 per outstanding share of Series F Preferred Stock.

Redemption. All shares of Series F Preferred Stock that are not present in person or by proxy at any meeting of stockholders held to vote on the Reverse Stock Split and the Adjournment Proposal as of immediately prior to the opening of the polls at such meeting (the “Initial Redemption Time”) will automatically be redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series F Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series F Preferred Stock that have not been redeemed pursuant to an Initial Redemption will be redeemed in whole, but not in part, (i) if such redemption is ordered by the Board in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at any meeting of the stockholders held for the purpose of voting on such proposal.

Each share of Series F Preferred Stock redeemed in any redemption described above will be redeemed in consideration for the right to receive an amount equal to $0.10 in cash for each ten whole shares of Series F Preferred Stock that are “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation with respect to the Series F Preferred Stock (the “Certificate of Designation”)) thereof as of the applicable redemption time and redeemed pursuant to such redemption, payable upon receipt by the Company of a written request submitted by the applicable holder to the corporate secretary of the Company (each a “Redemption Payment Request”) following the applicable redemption time. Such Redemption Payment Request shall (i) be in a form reasonably acceptable to the Company (ii) set forth in reasonable detail the number of shares of Series F Preferred Stock beneficially owned by the holder at the applicable redemption time and include evidence reasonably satisfactory to the Company regarding the same, and (iii) set forth a calculation specifying the amount in cash owed to such Holder by the Company with respect to the shares of Series F Preferred Stock that were redeemed at the applicable redemption time. However, the redemption consideration in respect of the shares of Series F Preferred Stock (or fractions thereof) redeemed in any redemption described above: (i) will entitle the former beneficial owners of less than ten whole shares of Series F Preferred Stock redeemed in any redemption to no cash payment in respect thereof and (y) will, in the case of a former beneficial owner of a number of shares of Series F Preferred Stock (or fractions thereof) redeemed pursuant to any redemption that is not equal to a whole number that is a multiple of ten, entitle such beneficial owner to the same cash payment, if any, in respect of such redemption as would have been payable in such redemption to such beneficial owner if the number of shares (or fractions thereof) beneficially owned by such beneficial owner and redeemed pursuant to such redemption were rounded down to the nearest whole number that is a multiple of ten (such, that for example, the former beneficial owner of 25 shares of Series F Preferred Stock redeemed pursuant to any redemption will be entitled to receive the same cash payment in respect of such redemption as would have been payable to the former beneficial owner of 20 shares of Series F Preferred Stock redeemed pursuant to such redemption).

The Series F Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series F Preferred Stock has no stated maturity and is not subject to any sinking fund. The Series F Preferred Stock is not subject to any restriction on the redemption or repurchase of shares by the Company while there is any arrearage in the payment of dividends or sinking fund installments.

The Certificate of Designation was filed with the Delaware Secretary of State and became effective on March 16, 2023. The foregoing description of the Series F Preferred Stock does not purport to be complete and is qualified in its entirety by reference to the Certificate of Designation, which is filed as Exhibit 3.1 to this Current Report and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On March 16, 2023, the Company issued a press release announcing the Series F Preferred Stock dividend. A copy of that press release is furnished as Exhibit 99.1 to this Current Report and incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in Exhibit 99.1, which is incorporated into this Item 7.01, is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing.

 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Predictive Oncology Inc.
     
   
Date: March 16, 2023 By:  /s/ Bob Myers        
    Bob Myers
    Chief Financial Officer
   

 

 EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock

EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on March 27, 2023. The shares of Series F Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on March 27, 2023. The outstanding shares of Series F Preferred Stock will vote together with the outstanding shares of the Company’s common stock, as a single class, exclusively with respect to a reverse stock split, as well as any proposal to adjourn any meeting of stockholders called for the purpose of voting on the reverse stock split, and will not be entitled to vote on any other matter, except to the extent required under the Delaware General Corporation Law. Subject to certain limitations, each outstanding share of Series F Preferred Stock will have 1,000,000 votes per share (or 1,000 votes per one one-thousandth of a share of Series F Preferred Stock).

All shares of Series F Preferred Stock that are not present in person or by proxy at the meeting of stockholders held to vote on the reverse stock split as of immediately prior to the opening of the polls at such meeting will automatically be redeemed by the Company. Any outstanding shares of Series F Preferred Stock that have not been so redeemed will be redeemed if such redemption is ordered by the Company’s Board of Directors or automatically upon the approval by the Company’s stockholders of an amendment to the Company’s certificate of incorporation effecting the reverse stock split at such meeting.

The Series F Preferred Stock will be uncertificated, and no shares of Series F Preferred Stock will be transferable by any holder thereof except in connection with a transfer by such holder of any shares of the Company’s common stock held by such holder. In that case, a number of one one-thousandths of a share of Series F Preferred Stock equal to the number of shares of the Company’s common stock to be transferred by such holder would be transferred to the transferee of such shares of common stock.

Further details regarding the Series F Preferred Stock will be contained in a report on Form 8-K to be filed by the Company with the Securities and Exchange Commission.

About Predictive Oncology Inc.

As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology (NASDAQ: POAI) offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of over 150K tumor samples. Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise.

Forward Looking Statements:

Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, changes in management, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.

Bob Myers, CFO
Predictive Oncology Inc.
bmyers@predictive-oncology.com

 EX-101.SCH 3 gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Mar. 16, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 16, 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-36790
Entity Registrant Name Predictive Oncology Inc.
Entity Central Index Key 0001446159
Entity Tax Identification Number 33-1007393
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2915 Commers Drive, Suite 900
Entity Address, City or Town Eagan
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55121
City Area Code 651
Local Phone Number 389-4800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.01 par value
Trading Symbol POAI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 f8k_031623_htm.xml IDEA: XBRL DOCUMENT 0001446159 2023-03-16 2023-03-16 iso4217:USD shares iso4217:USD shares 0001446159 false --12-31 8-K 2023-03-16 Predictive Oncology Inc. DE 001-36790 33-1007393 2915 Commers Drive, Suite 900 Eagan MN 55121 651 389-4800 false false false false Common stock, $0.01 par value POAI NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_031623.htm exh_991.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_031623.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 23 }, "contextCount": 1, "dts": { "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "inline": { "local": [ "f8k_031623.htm" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_031623.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://globenewswire.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_031623.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001171843-23-001737-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-23-001737-xbrl.zip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